Converting the maybes: Crucial for a successful COVID-19 vaccination strategy

被引:60
作者
Attwell, Katie [1 ,2 ,3 ]
Lake, Joshua [4 ]
Sneddon, Joanne [4 ]
Gerrans, Paul [4 ]
Blyth, Chris [2 ,3 ,5 ,6 ]
Lee, Julie [4 ]
机构
[1] Univ Western Australia, Sch Social Sci, Perth, WA, Australia
[2] Univ Western Australia, Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia
[3] Univ Western Australia, Sch Med, Perth, WA, Australia
[4] Univ Western Australia, Ctr Human & Cultural Values, Perth, WA, Australia
[5] Perth Childrens Hosp, Dept Paediat Infect Dis, Perth, WA, Australia
[6] QEII Med Ctr, PathWest Lab Med WA, Dept Microbiol, Perth, WA, Australia
基金
澳大利亚研究理事会;
关键词
D O I
10.1371/journal.pone.0245907
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Broad community acceptance of a COVID-19 vaccination will be critical for effectively halting the spread of the virus. In this study, we focus on factors that differentiate those who are undecided from those who are either willing or unwilling to accept a prospective COVID-19 vaccine. Methods An online survey in May 2020 assessed Australian adults' willingness to receive a COVID-19 vaccine (yes, maybe, no). A multinomial logistical regression of responses (N = 1,313) was used to identify correlates of vaccine willingness between the three groups. Results 65% were willing to vaccinate, with 27% being in the 'maybe' category. Respondents were more likely to be in the 'maybe' than the 'yes' group when they perceived COVID-19 to be less severe, had less trust in science, were less willing to vaccinate for influenza, and were female. They were more likely to be in the 'maybe' than 'no' group when they perceived COVID-19 as severe, and less likely to be a hoax, had more trust in science, and greater willingness to vaccinate for influenza. A repeat of the survey in November 2020 with a subset of participants found fewer of them saying yes to the vaccine (56%) and more saying maybe (31%). Conclusions The effectiveness of any COVID-19 vaccine rollout will be reliant on maximizing uptake. The significant number of people who remain undecided about whether or not to get a COVID-19 vaccine, despite the ongoing devastating consequences of the virus for individuals, communities, and economies, is concerning. Our findings aid current research seeking to inform policy regarding how to convince the undecided to vaccinate.
引用
收藏
页数:8
相关论文
共 21 条
[1]  
[Anonymous], 2020, ABC NEWS, DOI DOI 10.1080/01490400.2022.2062076
[2]  
Australian Government Department of Health., 2020, NAT IMM PROGR INFL V
[3]  
Australian Government Department of Health, AUSTR COVID 19 VACC
[4]  
Australian Government Department of Health., REC FLU VACC 2020 PR
[5]   Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic [J].
Detoc, Maelle ;
Bruel, Sebastien ;
Frappe, Paul ;
Tardy, Bernard ;
Botelho-Nevers, Elisabeth ;
Gagneux-Brunon, Amandine .
VACCINE, 2020, 38 (45) :7002-7006
[6]   Willingness to vaccinate against COVID-19 in Australia [J].
Dodd, Rachael H. ;
Cvejic, Erin ;
Bonner, Carissa ;
Pickles, Kristen ;
McCaffery, Kirsten J. .
LANCET INFECTIOUS DISEASES, 2021, 21 (03) :318-319
[7]   Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public [J].
Eastwood, Keith ;
Durrheim, David N. ;
Jones, Alison ;
Butler, Michelle .
MEDICAL JOURNAL OF AUSTRALIA, 2010, 192 (01) :33-36
[8]  
European Social Survey, ESS COR QUEST DEV PO
[9]  
Gallagher J, 2020, BBC News
[10]   Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey [J].
Goldman, Ran D. ;
Yan, Tyler D. ;
Seiler, Michelle ;
Cotanda, Cristina Parra ;
Brown, Julie C. ;
Klein, Eileen J. ;
Hoeffe, Julia ;
Gelernter, Renana ;
Hall, Jeanine E. ;
Davis, Adrienne L. ;
Griffiths, Mark A. ;
Mater, Ahmed ;
Manzano, Sergio ;
Gualco, Gianluca ;
Shimizu, Naoki ;
Hurt, Thomas L. ;
Ahmed, Sara ;
Hansen, Matt ;
Sheridan, David ;
Ali, Samina ;
Thompson, Graham C. ;
Gaucher, Nathalie ;
Staubli, Georg .
VACCINE, 2020, 38 (48) :7668-7673